Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
105 studies found for:    "neurofibromatosis type 1"
Show Display Options
RSS Create an RSS feed from your search for:
"neurofibromatosis type 1"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Neurofibromatosis Type 1 Patient Registry
Condition: Neurofibromatosis Type 1
Intervention:
2 Active, not recruiting A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Condition: Neurofibromatosis Type 1
Interventions: Drug: Lovastatin ™;   Device: placebo
3 Unknown  Multi-Center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients
Condition: Neurofibromatosis Type 1
Intervention:
4 Completed Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1
Condition: Neurofibromatosis Type 1
Intervention: Other: Neuropsychological examination and quality of life measures
5 Completed Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)
Condition: Neurofibromatosis Type 1
Intervention:
6 Unknown  A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
Condition: Neurofibromatosis Type 1
Intervention: Drug: Sirolimus, Rapamycin
7 Completed NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate
Condition: Neurofibromatosis Type 1
Intervention: Drug: methylphenidate
8 Completed Effects of Physical Training on Bone and Muscle Quality, Muscle Strength, and Motor Coordination in Children With NF1
Condition: Neurofibromatosis Type 1
Intervention: Other: Plyometric training program
9 Recruiting Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma
Condition: Neurofibromatosis Type 1
Interventions: Device: Magnetic resonance imaging;   Drug: Gadolinium contrast
10 Unknown  How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem
Condition: Neurofibromatosis Type 1
Intervention:
11 Recruiting Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1
Condition: Neurofibromatosis Type 1
Interventions: Other: CogmedRM;   Other: Mobymax
12 Unknown  Analysis of Peripheral Nerve Sheath Tumors (PNSTs) in Neurofibromatosis Type 1 (NF1) Patients
Condition: Neurofibromatosis Type 1
Intervention:
13 Unknown  Microarray CGH Analysis of Circulating Tumoral Plasma DNA in NF1 Patients With MPNSTs
Condition: Neurofibromatosis Type 1
Intervention:
14 Recruiting Effect of Lamotrigine on Cognition in NF1
Condition: Neurofibromatosis Type 1
Interventions: Drug: Lamotrigine;   Drug: Placebo
15 Unknown  Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.
Condition: Neurofibromatosis Type 1
Intervention:
16 Not yet recruiting Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)
Condition: Neurofibromatosis Type 1 (NF1)
Intervention: Drug: Cholecalciferol
17 Completed Reading Disability in Children With NF1
Condition: Neurofibromatosis Type 1
Intervention: Other: Neuropsychological assessments
18 Completed Functional Imaging and Reading Deficit in Children With NF1
Condition: Neurofibromatosis Type 1
Interventions: Other: Neuropsychological assessments;   Radiation: morphological and functional MRI (fMRI);   Genetic: genetic analysis
19 Completed Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1;   Precancerous Condition
Intervention: Drug: pirfenidone
20 Not yet recruiting Subtle Myocardial Deformation Abnormalities in Asymptomatic Nf-1 Patients
Condition: Neurofibromatosis Type 1
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.